Detection of <i>PTCH1</i> Copy-Number Variants in Mosaic Basal Cell Nevus Syndrome
Guido M. J. M. Roemen,
Tom E. J. Theunissen,
Ward W. J. Hoezen,
Anja R. M. Steyls,
Aimee D. C. Paulussen,
Klara Mosterd,
Elisa Rahikkala,
Axel zur Hausen,
Ernst Jan M. Speel,
Michel van Geel
Affiliations
Guido M. J. M. Roemen
Department of Pathology, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands
Tom E. J. Theunissen
Department of Pathology, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands
Ward W. J. Hoezen
Department of Dermatology, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands
Anja R. M. Steyls
Department of Clinical Genetics, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands
Aimee D. C. Paulussen
GROW School for Oncology and Reproduction, Maastricht University, 6229 ER Maastricht, The Netherlands
Klara Mosterd
GROW School for Oncology and Reproduction, Maastricht University, 6229 ER Maastricht, The Netherlands
Elisa Rahikkala
Research Unit of Clinical Medicine, Department of Clinical Genetics, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, 90570 Oulu, Finland
Axel zur Hausen
Department of Pathology, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands
Ernst Jan M. Speel
Department of Pathology, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands
Michel van Geel
GROW School for Oncology and Reproduction, Maastricht University, 6229 ER Maastricht, The Netherlands
Basal cell nevus syndrome (BCNS) is an inherited disorder characterized mainly by the development of basal cell carcinomas (BCCs) at an early age. BCNS is caused by heterozygous small-nucleotide variants (SNVs) and copy-number variants (CNVs) in the Patched1 (PTCH1) gene. Genetic diagnosis may be complicated in mosaic BCNS patients, as accurate SNV and CNV analysis requires high-sensitivity methods due to possible low variant allele frequencies. We compared test outcomes for PTCH1 CNV detection using multiplex ligation-probe amplification (MLPA) and digital droplet PCR (ddPCR) with samples from a BCNS patient heterozygous for a PTCH1 CNV duplication and the patient’s father, suspected to have a mosaic form of BCNS. ddPCR detected a significantly increased PTCH1 copy-number ratio in the index patient’s blood, and the father’s blood and tissues, indicating that the father was postzygotic mosaic and the index patient inherited the CNV from him. MLPA only detected the PTCH1 duplication in the index patient’s blood and in hair and saliva from the mosaic father. Our data indicate that ddPCR more accurately detects CNVs, even in low-grade mosaic BCNS patients, which may be missed by MLPA. In general, quantitative ddPCR can be of added value in the genetic diagnosis of mosaic BCNS patients and in estimating the recurrence risk for offspring.